share_log

Altamira Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Rosalind Advisors, Inc.(8.3%),Steven Salamon(8.3%), etc.

SEC ·  Aug 11, 2018 02:55
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.